Nakin, Freddy and Joe sit down live in San Diego before their presentation at MGMA to bring in the sixth episode of BYOB: The Healthcare Podcast. The team speaks to Shruti Kothari on Innovation and Insurance, Shruti is the Director of Strategic Initiatives at Blue Shield of California. Throughout her career, Shruti has had stops as a health educator, in venture capital and at a prominent healthcare provider. She discusses how her experience working in county hospitals highlighted the disparities within healthcare and why she decided to jump into the healthcare space to try and make a change.
Shruti shares great perspective on what early careerists should think of when they are looking to pursue a new opportunity, start a new organization/company and what she learned from working in the Venture Capital space. Additionally, Shruti shares how striking statistics in early seed funding compounded by events that affected the entire nation, moved her to elevate the voices of women of color and call attention to the staggering low number of executives who are women of color.
Shruti Kothari – Blue Shield of California
Shruti Kothari is a healthcare transformation advocate. She leads Industry Initiatives for Blue Shield of California, focusing on industry alignment, collaboration, and policy movement that drives the change needed to scale BSC’s Innovation and transformation agenda.
Prior to BSC, Shruti led Strategic Engagement for Kaiser Permanente’s venture capital fund, integrating early-stage startups into the Kaiser Permanente ecosystem. She also worked as an early-stage startup operator for Honor, healthcare system quality improvement leader for Kaiser Permanente, and a health educator and community mobilizer for the American Cancer Society.
Shruti is on the board for Family Caregiver Alliance, as well as an Advisor for the End Well Foundation. She is the founder of Women of Community which engages in advocacy efforts to increase representation of Women of Color in healthcare leadership. You can follow Women of Community (WOC) on Instagram and LinkedIn. The crew asked Shruti the following questions:
Talking with Nakin – Merck Antiviral COVID-19 Treatment
Nakin speaks with the group about a new treatment by Merck to reduce the risk of hospitalization and death once an individual has contracted the COVID-19. The groups discuss the effect of introducing an antiviral treatment for COVID-19 into the mix of current treatment options and what that means for patients here in the United States along with the rest of the world.
We’d be interested to know from our listeners how they view the ongoing dynamic of the availability of vaccines and treatment options for COVID-19. Would you be willing to take a pill to treat the effect from COVID-19?